{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:27:30Z","timestamp":1790249250770,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10549-013-2667-y","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T06:24:10Z","timestamp":1376893450000},"page":"55-65","source":"Crossref","is-referenced-by-count":93,"title":["Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells"],"prefix":"10.1007","volume":"141","author":[{"given":"Angela","family":"Catania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Barraj\u00f3n-Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cicirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Micol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,20]]},"reference":[{"issue":"6050","key":"2667_CR1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/319230a0","volume":"319","author":"T Yamamoto","year":"1986","unstructured":"Yamamoto T et al (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319(6050):230\u2013234","journal-title":"Nature"},{"issue":"6050","key":"2667_CR2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/319226a0","volume":"319","author":"CI Bargmann","year":"1986","unstructured":"Bargmann CI, Hung MC, Weinberg RA (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319(6050):226\u2013230","journal-title":"Nature"},{"issue":"7","key":"2667_CR3","first-page":"953","volume":"5","author":"MF Press","year":"1990","unstructured":"Press MF, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER-2\/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5(7):953\u2013962","journal-title":"Oncogene"},{"key":"2667_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(87)92736-X","volume":"2","author":"DJ Venter","year":"1987","unstructured":"Venter DJ, Fau-Tuzi NL et al (1987) Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 2:69\u201372","journal-title":"Lancet"},{"issue":"4 Suppl. 12","key":"2667_CR5","first-page":"108","volume":"26","author":"MS Mitchell","year":"1999","unstructured":"Mitchell MS, Press MF (1999) The role of immunohistochemistry and fluorescence in situ hybridization for HER-2\/neu in assessing the prognosis of breast cancer. Semin Oncol 26(4 Suppl. 12):108\u2013116","journal-title":"Semin Oncol"},{"issue":"4785","key":"2667_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235(4785):177\u2013182","journal-title":"Science"},{"key":"2667_CR7","first-page":"57","volume":"13","author":"PM Fau","year":"2000","unstructured":"Fau PM et al (2000) The molecular and cellular biology of HER2\/neu gene amplification\/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer. Cancer Treat Res 13:57\u201375","journal-title":"Cancer Treat Res"},{"issue":"10","key":"2667_CR8","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.89.10.4285","volume":"89","author":"P Carter","year":"1992","unstructured":"Carter P et al (1992) Humanization of an anti-p185(HER2) antibody for human cancer therapy. Proc Natl Acad Sci USA 89(10):4285\u20134289","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2667_CR9","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","volume":"17","author":"MA Cobleigh","year":"1999","unstructured":"Cobleigh MA et al (1999) Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17(9):2639\u20132648","journal-title":"J Clin Oncol"},{"issue":"11","key":"2667_CR10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ et al (2001) Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344(11):783\u2013792","journal-title":"N Engl J Med"},{"issue":"3","key":"2667_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12263-007-0059-9","volume":"2","author":"G Filomeni","year":"2007","unstructured":"Filomeni G et al (2007) Trans-resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr 2(3):295\u2013305","journal-title":"Genes Nutr"},{"issue":"2","key":"2667_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1568009053202081","volume":"5","author":"D Karunagaran","year":"2005","unstructured":"Karunagaran D, Rashmi R, Kumar TRS (2005) Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 5(2):117\u2013129","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"2667_CR13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2011.09.083","volume":"158","author":"A Amri","year":"2012","unstructured":"Amri A et al (2012) Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 158(2):182\u2013193","journal-title":"J Control Release"},{"issue":"2","key":"2667_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","volume":"269","author":"AB Kunnumakkara","year":"2008","unstructured":"Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269(2):199\u2013225","journal-title":"Cancer Lett"},{"issue":"2","key":"2667_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijpharm.2011.01.056","volume":"416","author":"M Coimbra","year":"2011","unstructured":"Coimbra M et al (2011) Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm 416(2):433\u2013442","journal-title":"Int J Pharm"},{"issue":"2","key":"2667_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jconrel.2011.10.019","volume":"160","author":"M Coimbra","year":"2012","unstructured":"Coimbra M et al (2012) Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines. J Control Release 160(2):232\u2013238","journal-title":"J Control Release"},{"issue":"1","key":"2667_CR17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","volume":"268","author":"AL Klibanov","year":"1990","unstructured":"Klibanov AL et al (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268(1):235\u2013237","journal-title":"FEBS Lett"},{"issue":"24","key":"2667_CR18","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","volume":"88","author":"D Papahadjopoulos","year":"1991","unstructured":"Papahadjopoulos D et al (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 88(24):11460\u201311464","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2667_CR19","first-page":"1484","volume":"53","author":"I Ahmad","year":"1993","unstructured":"Ahmad I et al (1993) Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 53(7):1484\u20131488","journal-title":"Cancer Res"},{"issue":"3","key":"2667_CR20","first-page":"1541","volume":"282","author":"J Huwyler","year":"1997","unstructured":"Huwyler J, Yang J, Pardridge WM (1997) Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther 282(3):1541\u20131546","journal-title":"J Pharmacol Exp Ther"},{"issue":"7\u20138","key":"2667_CR21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1345\/aph.10054","volume":"34","author":"KR Reddy","year":"2000","unstructured":"Reddy KR (2000) Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs. Ann Pharmacother 34(7\u20138):915\u2013923","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2667_CR22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2009.09.010","volume":"290","author":"E Barrajon-Catalan","year":"2010","unstructured":"Barrajon-Catalan E et al (2010) Selective death of human breast cancer cells by lytic immunoliposomes: correlation with their HER2 expression level. Cancer Lett 290(2):192\u2013203","journal-title":"Cancer Lett"},{"key":"2667_CR23","doi-asserted-by":"crossref","unstructured":"Barraj\u00f3n-Catal\u00e1n E et al (2011) Immunoliposomes: A Multipurpose Strategy in Breast Cancer Targeted Therapy, in Breast Cancer\u2014Current and Alternative Therapeutic Modalities, Intech, Editor, p 435\u2013452","DOI":"10.5772\/23998"},{"issue":"2","key":"2667_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0031-6865(95)00010-7","volume":"70","author":"S Vemuri","year":"1995","unstructured":"Vemuri S, Rhodes CT (1995) Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helv 70(2):95\u2013111","journal-title":"Pharm Acta Helv"},{"issue":"2","key":"2667_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(95)00138-S","volume":"1239","author":"CB Hansen","year":"1995","unstructured":"Hansen CB et al (1995) Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim Biophys Acta 1239(2):133\u2013144","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"2667_CR26","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1021\/jf073105v","volume":"56","author":"CE Green","year":"2008","unstructured":"Green CE et al (2008) Extraction, processing, and storage effects on curcuminoids and oleoresin yields from Curcuma longa L. grown in Jamaica. J Agric Food Chem 56(10):3664\u20133670","journal-title":"J Agric Food Chem"},{"issue":"1\u20132","key":"2667_CR27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0021-9673(00)00960-2","volume":"907","author":"L Chen","year":"2001","unstructured":"Chen L et al (2001) High-speed counter-current chromatography separation and purification of resveratrol and piceid from Polygonum cuspidatum. J Chromatogr A 907(1\u20132):343\u2013346","journal-title":"J Chromatogr A"},{"issue":"2","key":"2667_CR28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cancergencyto.2006.09.014","volume":"172","author":"K Rennstam","year":"2007","unstructured":"Rennstam K et al (2007) Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1. Cancer Genet Cytogenet 172(2):95\u2013106","journal-title":"Cancer Genet Cytogenet"},{"issue":"12","key":"2667_CR29","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1535-7163.1585.3.12","volume":"3","author":"M Tanner","year":"2004","unstructured":"Tanner M et al (2004) Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. Mol Cancer Ther 3(12):1585\u20131592","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"2667_CR30","first-page":"7456","volume":"61","author":"KPL Bhat","year":"2001","unstructured":"Bhat KPL et al (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61(20):7456\u20137463","journal-title":"Cancer Res"},{"issue":"2","key":"2667_CR31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2012.12.004","volume":"97","author":"A Falco","year":"2013","unstructured":"Falco A et al (2013) Melittin-loaded immunoliposomes against viral surface proteins, a new approach to antiviral therapy. Antiviral Res 97(2):218\u2013221","journal-title":"Antiviral Res"},{"issue":"4","key":"2667_CR32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/pharmaceutics3040793","volume":"3","author":"A Munin","year":"2011","unstructured":"Munin A, Edwards-L\u00e9vy F (2011) Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics 3(4):793\u2013829","journal-title":"Pharmaceutics"},{"issue":"1","key":"2667_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.24336","volume":"125","author":"NK Narayanan","year":"2009","unstructured":"Narayanan NK et al (2009) Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125(1):1\u20138","journal-title":"Int J Cancer"},{"issue":"19","key":"2667_CR34","first-page":"5135","volume":"52","author":"SK Huang","year":"1992","unstructured":"Huang SK et al (1992) Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res 52(19):5135\u20135143","journal-title":"Cancer Res"},{"issue":"4","key":"2667_CR35","first-page":"1172","volume":"8","author":"JW Park","year":"2002","unstructured":"Park JW et al (2002) Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res 8(4):1172\u20131181","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2667_CR36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/bi962148u","volume":"36","author":"D Kirpotin","year":"1997","unstructured":"Kirpotin D et al (1997) Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 36(1):66\u201375","journal-title":"Biochemistry"},{"issue":"24","key":"2667_CR37","doi-asserted-by":"crossref","first-page":"11631","DOI":"10.1158\/0008-5472.CAN-05-1093","volume":"65","author":"C Mamot","year":"2005","unstructured":"Mamot C et al (2005) Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res 65(24):11631\u201311638","journal-title":"Cancer Res"},{"issue":"3","key":"2667_CR38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/1078-0432.CCR-03-0041","volume":"10","author":"P Sapra","year":"2004","unstructured":"Sapra P et al (2004) Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via Anti-CD19 IgG2a or Fab fragments. Clin Cancer Res 10(3):1100\u20131111","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2667_CR39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/bp049840y","volume":"21","author":"DF Nellis","year":"2005","unstructured":"Nellis DF et al (2005) Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification. Biotechnol Prog 21(1):205\u2013220","journal-title":"Biotechnol Prog"},{"issue":"3","key":"2667_CR40","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/jf9035782","volume":"58","author":"JN Lin","year":"2010","unstructured":"Lin JN et al (2010) Resveratrol modulates tumor cell proliferation and protein translation via SIRT1 -dependent AMPK activation. J Agric Food Chem 58(3):1584\u20131592","journal-title":"J Agric Food Chem"},{"issue":"4","key":"2667_CR41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4161\/cc.23756","volume":"12","author":"JA Menendez","year":"2013","unstructured":"Menendez JA, Fau-Joven J et al (2013) Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: A new family of gerosuppressant agents. Cell Cycle 12(4):555\u2013578","journal-title":"Cell Cycle"},{"issue":"11","key":"2667_CR42","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2008.07.031","volume":"76","author":"S Reuter","year":"2008","unstructured":"Reuter S et al (2008) Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76(11):1340\u20131351","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"2667_CR43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789\u2013799","journal-title":"Nat Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2667-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2667-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T22:59:22Z","timestamp":1688425162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2667-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2667"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2667-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}